TF and neoplasm: Here, we develop a prognostic signature based on IGV which is independent of well-known clinical prognostic features, and show that this IGV prognostic signature is likely a surrogate readout reflecting a mixture of intra-tumour heterogeneity and transcription factor (TF) binding/activity.